Skip to main navigation Skip to search Skip to main content

Anti-CCL3 autoantibodies are not markers of type 1 diabetes when measured by a commercial ELISA method

  • Helmholtz Zentrum München German Research Center for Environmental Health
  • Center for Regenerative Therapies Dresden

Research output: Contribution to journalArticlepeer-review

1 Scopus citations
Original languageEnglish
Pages (from-to)699-700
Number of pages2
JournalDiabetologia
Volume54
Issue number3
DOIs
StatePublished - Mar 2011
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Autoantibody
  • CCL3
  • ELISA
  • Type 1 diabetes

Cite this